Project Grant R01HL154538
Award Date
2/1/21
Completion Date
8/31/21
Dollars Obligated
$512K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research to investigate the role of perivascular macrophages in promoting endothelial cell regeneration and vascular repair following acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). The $1,875,540 award, with a period of performance from June 15, 2024 to March 31, 2029, will enable researchers at the...
The University of Illinois received a $607,535 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award, effective September 17, 2024 through August 31, 2025, supports research to evaluate the effects of hemin, a breakdown product of cell-free hemoglobin, on the pulmonary endothelium and its contribution to the acute and chronic pulmonary complications of sickle cell disease. The research aims to...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), supports comprehensive research focused on understanding the role of macrophage inflammation in the pathophysiology of acute ischemic injury and heart failure. The $2,183,648 award to Northwestern University, with a sub-award to Ann & Robert H. Lurie Children's Hospital of Chicago, aims to elucidate the underlying causal...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will provide $598,228 to the University of Illinois to study the role of ER-phagy (endoplasmic reticulum autophagy) in the immune response during sepsis. The research aims to define the mechanisms by which ER-phagy regulates the NLRP3 inflammasome activation and cytokine release in macrophages, leading to lung injury in sepsis. The project will...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $549,665 Project Grant under CFDA 93.837, the Cardiovascular Diseases Research program, to the University of Maryland, Baltimore. The grant will fund research to define the mechanisms by which the protein testisin regulates the resolution of angiogenesis, the formation of new blood vessels, and to evaluate the therapeutic potential of augmenting the testisin pathway to promote vascular normalization. The research aims to advance the...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $230,684 to support research on the function of the endothelin receptor-B (EDNRB) in perivascular macrophages. The project aims to assess the iron content and transcriptional profile of perivascular macrophages, identify the function of EDNRB signaling in these cells, and determine the role of the transcription factor BACH1 in...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $480,990 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Illinois to conduct research on the role of aerocytes, a recently identified lung cell population, in promoting alveolar epithelial regeneration following acute respiratory distress syndrome (ARDS). The project aims to establish the central role of aerocytes in regulating alveolar regeneration through signaling molecules like...
The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $1,127,798 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). This grant, with a performance period from February 1, 2025 to January 31, 2032, will support research to understand the role of macrophages in preserving cardiovascular health, illuminating...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) will provide $706,220 to the University of Illinois to conduct research on the role of nuclear pore components in vascular function and atherosclerosis. The research aims to elucidate how phosphorylation of the nucleoporin NUP93 affects nuclear localization of the transcriptional co-factor YAP, and how this impacts endothelial cell...
This $108,405 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will support research at The Washington University in St. Louis to investigate the role of primary cilia on endothelial cells in regulating vascular stability and development. The key objectives are to determine how endothelial cell primary cilia respond to changes in blood flow, define the mechanism by which primary cilia...